Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Small Cell Lung Carcinoma
×
Doxorubicin
×
Clear all
Filters
3
NCT02566993
2021-10-28
ATLANTIS
PharmaMar
Phase 3
Completed
613 enrolled
46 charts
NCT00483509
2019-10-04
NGR007
AGC Biologics S.p.A.
Phase 2
Completed
28 enrolled
10 charts